XTLB

XTL Biopharmaceuticals Ltd. American Depositary Shares

$2.44 -0.81%

Recent alerts on XTLB

All signals →

News XTL receives Nasdaq staff delist notice for failing to file annual report

News XTL Biopharmaceuticals Confirms Board and Auditor Appointments - Investing.com

Failures to deliver 303,157 shares failed to deliver

SEC filing XTLB Reports $0 Revenue, $0 EPS, No Deals, Israel-Based Biopharma

Scanner Large up move: 54.8% (3.8x normal daily movement)

Scanner Large up move: 54.8% (3.9x normal daily movement)

News XTL Biopharmaceuticals to acquire Psyga Bio in all-stock deal; shares surge

SEC filing XTLB Acquires Psyga Bio for $5.5M, 338,990 Shares, 100% Ownership, Interested Party Deal Approved

News XTL announces receipt of staff delisting letter from Nasdaq

Short volume Short volume 77% of volume (3.6σ)

SEC filing XTLB No Reportable Items

News Beyond Air Deals Autism-Focused NeuroNOS To XTL For Equity, Future Payments

News XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

News XTL Biopharmaceuticals receives Nasdaq bid price deficiency notice

Get push alerts for XTLB

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS